Top

Newsroom

December 2023 Archive

ASH: Novel menin inhibitors show promise for patients with...

December 09, 2023

ABSTRACTS: 57, 58 Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early...

MD Anderson and Rigel Pharmaceuticals announce strategic...

BY Clayton Boldt

December 08, 2023

The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development...

MD Anderson, TACC and the Oden Institute announce funding for the...

December 05, 2023

The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas...